These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 32928247

  • 1. Genetic diversity and different cross-neutralization capability of porcine circovirus type 2 isolates recently circulating in South Korea.
    Kang SJ, Kang H, You SH, Lee HJ, Lee N, Hyun BH, Cha SH.
    BMC Vet Res; 2020 Sep 14; 16(1):334. PubMed ID: 32928247
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of a porcine circovirus type 2a (PCV2a) vaccine efficacy against experimental PCV2a, PCV2b, and PCV2d challenge.
    Park KH, Oh T, Yang S, Cho H, Kang I, Chae C.
    Vet Microbiol; 2019 Apr 14; 231():87-92. PubMed ID: 30955830
    [Abstract] [Full Text] [Related]

  • 3. A chimeric virus created by DNA shuffling of the capsid genes of different subtypes of porcine circovirus type 2 (PCV2) in the backbone of the non-pathogenic PCV1 induces protective immunity against the predominant PCV2b and the emerging PCV2d in pigs.
    Matzinger SR, Opriessnig T, Xiao CT, Catanzaro N, Beach NM, Slade DE, Nitzel GP, Meng XJ.
    Virology; 2016 Nov 14; 498():82-93. PubMed ID: 27564544
    [Abstract] [Full Text] [Related]

  • 4. A Porcine circovirus type 2b (PCV2b)-based experimental vaccine is effective in the PCV2b-Mycoplasma hyopneumoniae coinfection pig model.
    Opriessnig T, Castro AMMG, Karuppanan AK, Gauger PC, Halbur PG, Matzinger SR, Meng XJ.
    Vaccine; 2019 Oct 16; 37(44):6688-6695. PubMed ID: 31537445
    [Abstract] [Full Text] [Related]

  • 5. A candidate DNA vaccine encoding a fusion protein of porcine complement C3d-P28 and ORF2 of porcine circovirus type 2 induces cross-protective immunity against PCV2b and PCV2d in pigs.
    Hou Z, Wang H, Feng Y, Li Q, Li J.
    Virol J; 2019 May 02; 16(1):57. PubMed ID: 31046793
    [Abstract] [Full Text] [Related]

  • 6. Porcine Circovirus Type 2 (PCV2) Vaccines in the Context of Current Molecular Epidemiology.
    Karuppannan AK, Opriessnig T.
    Viruses; 2017 May 06; 9(5):. PubMed ID: 28481275
    [Abstract] [Full Text] [Related]

  • 7. Porcine circovirus type 2a or 2b based experimental vaccines provide protection against PCV2d/porcine parvovirus 2 co-challenge.
    Opriessnig T, Karuppannan AK, Halbur PG, Calvert JG, Nitzel GP, Matzinger SR, Meng XJ.
    Vaccine; 2020 Feb 18; 38(8):1975-1981. PubMed ID: 31974016
    [Abstract] [Full Text] [Related]

  • 8. A PCV2 vaccine based on genotype 2b is more effective than a 2a-based vaccine to protect against PCV2b or combined PCV2a/2b viremia in pigs with concurrent PCV2, PRRSV and PPV infection.
    Opriessnig T, O'Neill K, Gerber PF, de Castro AM, Gimenéz-Lirola LG, Beach NM, Zhou L, Meng XJ, Wang C, Halbur PG.
    Vaccine; 2013 Jan 07; 31(3):487-94. PubMed ID: 23174198
    [Abstract] [Full Text] [Related]

  • 9. Porcine circovirus type 2 (PCV2) genotyping in Austrian pigs in the years 2002 to 2017.
    Weissenbacher-Lang C, Kristen T, Mendel V, Brunthaler R, Schwarz L, Weissenböck H.
    BMC Vet Res; 2020 Jun 15; 16(1):198. PubMed ID: 32539835
    [Abstract] [Full Text] [Related]

  • 10. T cell epitope content comparison (EpiCC) analysis demonstrates a bivalent PCV2 vaccine has greater T cell epitope overlap with field strains than monovalent PCV2 vaccines.
    Bandrick M, Gutiérrez AH, Desai P, Rincon G, Martin WD, Terry FE, De Groot AS, Foss DL.
    Vet Immunol Immunopathol; 2020 May 15; 223():110034. PubMed ID: 32278900
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Differential effects of porcine circovirus type 2 (PCV2) vaccination on PCV2 genotypes at Japanese pig farms.
    Takahagi Y, Toki S, Nishiyama Y, Morimatsu F, Murakami H.
    J Vet Med Sci; 2010 Jan 15; 72(1):35-41. PubMed ID: 19915335
    [Abstract] [Full Text] [Related]

  • 14. Prevalence and phylogenetic analysis of the current porcine circovirus 2 genotypes after implementation of widespread vaccination programmes in the USA.
    Shen HG, Halbur PG, Opriessnig T.
    J Gen Virol; 2012 Jun 15; 93(Pt 6):1345-1355. PubMed ID: 22398315
    [Abstract] [Full Text] [Related]

  • 15. [Occurrence of genotypes of porcine circovirus (PCV2) in pig farms using different vaccination strategies against PCV2].
    Eddicks M, Szikora F, Walhöfer N, Sauter Louis C, Reese S, Banholzer E, Reiner G, Sutter G, Ritzmann M, Fux R.
    Tierarztl Prax Ausg G Grosstiere Nutztiere; 2017 Apr 19; 45(2):90-97. PubMed ID: 28327779
    [Abstract] [Full Text] [Related]

  • 16. A commercial porcine circovirus (PCV) type 2a-based vaccine reduces PCV2d viremia and shedding and prevents PCV2d transmission to naïve pigs under experimental conditions.
    Opriessnig T, Xiao CT, Halbur PG, Gerber PF, Matzinger SR, Meng XJ.
    Vaccine; 2017 Jan 05; 35(2):248-254. PubMed ID: 27919634
    [Abstract] [Full Text] [Related]

  • 17. A commercial PCV2a-based vaccine is effective in protection from experimental challenge of PCV2 mutant with two amino acids elongation in capsid protein.
    Guo LJ, Fu YJ, Huang LP, Wang YP, Wei YW, Wu HL, Liu CM.
    Vaccine; 2015 Jul 17; 33(31):3752-7. PubMed ID: 26051516
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of cross-immunity among major porcine circovirus type 2 genotypes by infection with PCV2b and PCV2d circulating strains.
    Yu C, Cao M, Wei Y, Liu J, Zhang H, Liu C, Feng L, Huang L.
    Vet Microbiol; 2023 Aug 17; 283():109796. PubMed ID: 37285792
    [Abstract] [Full Text] [Related]

  • 19. Genetic and phylogenetic analysis of porcine circovirus type 2 on Jeju Island, South Korea, 2019-2020: evidence of a novel intergenotypic recombinant.
    Jang G, Yoo H, Kim Y, Yang K, Lee C.
    Arch Virol; 2021 Apr 17; 166(4):1093-1102. PubMed ID: 33570666
    [Abstract] [Full Text] [Related]

  • 20. Commercial PCV2a-based vaccines are effective in protecting naturally PCV2b-infected finisher pigs against experimental challenge with a 2012 mutant PCV2.
    Opriessnig T, Gerber PF, Xiao CT, Halbur PG, Matzinger SR, Meng XJ.
    Vaccine; 2014 Jul 23; 32(34):4342-8. PubMed ID: 24929119
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.